세계의 갈란타민브롬화수소산염 시장 보고서(2025년)

Galantamine hydrobromide is a pharmaceutical compound used to treat mild to moderate Alzheimer's disease and other memory-related conditions. As an acetylcholinesterase inhibitor, it works by increasing acetylcholine levels in the brain, which improves nerve signal transmission and cognitive function. Galantamine hydrobromide helps slow cognitive decline and enhances memory, attention, and overall mental function in patients with neurodegenerative disorders.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main galantamine hydrobromide products include tablets, capsules, and oral solutions. Tablets are solid forms of medicine taken orally, where they dissolve in the digestive system to release the active ingredients. Galantamine hydrobromide is used for treating Alzheimer's disease, enhancing cognitive function, and other purposes by various end-users, including hospitals, research institutions, homecare settings, and long-term care facilities.

The galantamine hydrobromide market research report is one of a series of new reports from The Business Research Company that provides galantamine hydrobromide market statistics, including galantamine hydrobromide industry global market size, regional shares, competitors with a galantamine hydrobromide market share, detailed galantamine hydrobromide market segments, market trends and opportunities, and any further data you may need to thrive in the galantamine hydrobromide industry. This galantamine hydrobromide market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The galantamine hydrobromide market size has grown rapidly in recent years. It will grow from $0.67 billion in 2024 to $0.74 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth observed during the historic period can be attributed to rising investments, a growing elderly population, an increasing diagnosis rate, heightened awareness of neurodegenerative illnesses, and a rise in life expectancy.

The galantamine hydrobromide market size is expected to see rapid growth in the next few years. It will grow to $1.08 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth projected during the forecast period can be attributed to an increase in clinical trials, a growing emphasis on early diagnosis, a rising incidence of Alzheimer's disease, expanded research funding and drug development efforts targeting Alzheimer's, and a strengthened focus on research and development. Key trends during this period include collaborations between pharmaceutical companies and research institutions, advancements in treatment options, the expansion of indications for galantamine hydrobromide through ongoing clinical trials, the rise of personalized medicine, and progress in biotechnology and pharmaceutical research.

The growing prevalence of Alzheimer's disease is expected to drive the expansion of the galantamine hydrobromide market over the forecast period. Alzheimer's disease is a progressive neurodegenerative disorder characterized by memory loss, cognitive decline, and behavioral changes, often impairing the ability to carry out everyday activities. The incidence of Alzheimer's is rising due to the aging global population, as the likelihood of developing the disease increases significantly with age due to accumulated brain changes and genetic predisposition. Galantamine hydrobromide is used to manage Alzheimer's symptoms by increasing acetylcholine levels through inhibition of its breakdown, thereby helping to slow cognitive decline and enhance memory in patients with reduced neurotransmitter function. For instance, in August 2024, the Centers for Disease Control and Prevention (CDC) reported that the number of individuals living with Alzheimer's in the U.S. is expected to rise from 6.9 million to nearly 14 million by 2060. Therefore, the increasing prevalence of Alzheimer's disease is driving the growth of the galantamine hydrobromide market.

Leading companies in the galantamine hydrobromide market are developing next-generation acetylcholinesterase inhibitors (AChEIs) to improve treatment outcomes, reduce side effects, and promote better patient adherence. These advanced AChEIs aim to enhance cognitive performance in neurodegenerative conditions by improving bioavailability while minimizing adverse effects. For example, in July 2024, Alpha Cognition Inc., a Canada-based biopharmaceutical company, received U.S. FDA approval for ALPHA-1062 (Zunveyl), a prodrug version of galantamine for mild to moderate Alzheimer's disease. ALPHA-1062 features improved safety and bioavailability compared to traditional formulations. Unlike standard galantamine, it is absorbed in the small intestine as an inert substance, avoiding early interaction with acetylcholinesterase in the gastrointestinal system. The addition of a benzyl ester helps reduce local neuronal overstimulation, lessens gastrointestinal side effects, and enhances bioavailability. Once metabolized in the liver, ALPHA-1062 becomes active and delivers galantamine efficiently to the brain through the bloodstream.

In April 2024, Essential Pharma Group Limited, a UK-based specialty pharmaceutical company, acquired the oral capsule formulation of Reminyl (galantamine hydrobromide) from Janssen Pharmaceutica NV for an undisclosed amount. This acquisition ensures the continued availability of and access to galantamine hydrobromide treatment for Alzheimer's patients. Janssen Pharmaceutica, a Belgium-based pharmaceutical company, is known for developing therapies across several fields including neurology, infectious diseases, immunology, oncology, and cardiology.

Major players in the galantamine hydrobromide market are Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Ajinomoto Co. Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Jubilant Pharmova Limited, Cohance Lifesciences Limited, Indena S.p.A., ScinoPharm Taiwan Ltd., Estechpharma Co. Ltd., Nortec Quimica S.A., Metrochem API Private Limited, Sanochemia Pharmazeutika AG, Pellets Pharma Limited, Midas Pharma GmbH, Jubilant Generics, Capital Farma, Wuhan Shiji Pharmaceutical Co. Ltd., Credo Life Sciences Pvt. Ltd.

North America was the largest region in the galantamine hydrobromide market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in galantamine hydrobromide report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the galantamine hydrobromide market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The galantamine hydrobromide market consists of sales of extended-release capsules, injectable solutions, transdermal patches, sublingual drops, and powder for compounding. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Galantamine Hydrobromide Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on galantamine hydrobromide market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for galantamine hydrobromide ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The galantamine hydrobromide market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Tablet; Capsule; Oral Solution
• 2) By Application: Alzheimer's Disease Treatment; Cognitive Enhancements; Other Applications
• 3) By End-User: Hospitals; Research Institutions; Homecare Settings; Long-term Care Facilities
• Subsegments:
• 1) By Tablet: Immediate-Release Tablets; Extended-Release Tablets
• 2) By Capsule: Hard Gelatin Capsules; Soft Gelatin Capsules
• 3) By Oral Solution: Ready-to-Use Oral Solution; Concentrated Oral Solution
• Companies Mentioned: Teva Pharmaceutical Industries Ltd.; Sandoz International GmbH; Ajinomoto Co. Inc.; Sun Pharmaceutical Industries Ltd.; Aurobindo Pharma Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Galantamine Hydrobromide Market Characteristics

3. Galantamine Hydrobromide Market Trends And Strategies

4. Galantamine Hydrobromide Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Galantamine Hydrobromide Growth Analysis And Strategic Analysis Framework

• 5.1. Global Galantamine Hydrobromide PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Galantamine Hydrobromide Market Growth Rate Analysis
• 5.4. Global Galantamine Hydrobromide Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Galantamine Hydrobromide Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Galantamine Hydrobromide Total Addressable Market (TAM)

6. Galantamine Hydrobromide Market Segmentation

• 6.1. Global Galantamine Hydrobromide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablet
• Capsule
• Oral Solution
• 6.2. Global Galantamine Hydrobromide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alzheimer's Disease Treatment
• Cognitive Enhancements
• Other Applications
• 6.3. Global Galantamine Hydrobromide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Research Institutions
• Homecare Settings
• Long-term Care Facilities
• 6.4. Global Galantamine Hydrobromide Market, Sub-Segmentation Of Tablet, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immediate-Release Tablets
• Extended-Release Tablets
• 6.5. Global Galantamine Hydrobromide Market, Sub-Segmentation Of Capsule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hard Gelatin Capsules
• Soft Gelatin Capsules
• 6.6. Global Galantamine Hydrobromide Market, Sub-Segmentation Of Oral Solution, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ready-to-Use Oral Solution
• Concentrated Oral Solution

7. Galantamine Hydrobromide Market Regional And Country Analysis

• 7.1. Global Galantamine Hydrobromide Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Galantamine Hydrobromide Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Galantamine Hydrobromide Market

• 8.1. Asia-Pacific Galantamine Hydrobromide Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Galantamine Hydrobromide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Galantamine Hydrobromide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Galantamine Hydrobromide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Galantamine Hydrobromide Market

• 9.1. China Galantamine Hydrobromide Market Overview
• 9.2. China Galantamine Hydrobromide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Galantamine Hydrobromide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Galantamine Hydrobromide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Galantamine Hydrobromide Market

• 10.1. India Galantamine Hydrobromide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Galantamine Hydrobromide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Galantamine Hydrobromide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Galantamine Hydrobromide Market

• 11.1. Japan Galantamine Hydrobromide Market Overview
• 11.2. Japan Galantamine Hydrobromide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Galantamine Hydrobromide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Galantamine Hydrobromide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Galantamine Hydrobromide Market

• 12.1. Australia Galantamine Hydrobromide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Galantamine Hydrobromide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Galantamine Hydrobromide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Galantamine Hydrobromide Market

• 13.1. Indonesia Galantamine Hydrobromide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Galantamine Hydrobromide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Galantamine Hydrobromide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Galantamine Hydrobromide Market

• 14.1. South Korea Galantamine Hydrobromide Market Overview
• 14.2. South Korea Galantamine Hydrobromide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Galantamine Hydrobromide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Galantamine Hydrobromide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Galantamine Hydrobromide Market

• 15.1. Western Europe Galantamine Hydrobromide Market Overview
• 15.2. Western Europe Galantamine Hydrobromide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Galantamine Hydrobromide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Galantamine Hydrobromide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Galantamine Hydrobromide Market

• 16.1. UK Galantamine Hydrobromide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Galantamine Hydrobromide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Galantamine Hydrobromide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Galantamine Hydrobromide Market

• 17.1. Germany Galantamine Hydrobromide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Galantamine Hydrobromide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Galantamine Hydrobromide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Galantamine Hydrobromide Market

• 18.1. France Galantamine Hydrobromide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Galantamine Hydrobromide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Galantamine Hydrobromide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Galantamine Hydrobromide Market

• 19.1. Italy Galantamine Hydrobromide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Galantamine Hydrobromide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Galantamine Hydrobromide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Galantamine Hydrobromide Market

• 20.1. Spain Galantamine Hydrobromide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Galantamine Hydrobromide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Galantamine Hydrobromide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Galantamine Hydrobromide Market

• 21.1. Eastern Europe Galantamine Hydrobromide Market Overview
• 21.2. Eastern Europe Galantamine Hydrobromide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Galantamine Hydrobromide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Galantamine Hydrobromide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Galantamine Hydrobromide Market

• 22.1. Russia Galantamine Hydrobromide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Galantamine Hydrobromide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Galantamine Hydrobromide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Galantamine Hydrobromide Market

• 23.1. North America Galantamine Hydrobromide Market Overview
• 23.2. North America Galantamine Hydrobromide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Galantamine Hydrobromide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Galantamine Hydrobromide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Galantamine Hydrobromide Market

• 24.1. USA Galantamine Hydrobromide Market Overview
• 24.2. USA Galantamine Hydrobromide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Galantamine Hydrobromide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Galantamine Hydrobromide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Galantamine Hydrobromide Market

• 25.1. Canada Galantamine Hydrobromide Market Overview
• 25.2. Canada Galantamine Hydrobromide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Galantamine Hydrobromide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Galantamine Hydrobromide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Galantamine Hydrobromide Market

• 26.1. South America Galantamine Hydrobromide Market Overview
• 26.2. South America Galantamine Hydrobromide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Galantamine Hydrobromide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Galantamine Hydrobromide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Galantamine Hydrobromide Market

• 27.1. Brazil Galantamine Hydrobromide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Galantamine Hydrobromide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Galantamine Hydrobromide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Galantamine Hydrobromide Market

• 28.1. Middle East Galantamine Hydrobromide Market Overview
• 28.2. Middle East Galantamine Hydrobromide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Galantamine Hydrobromide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Galantamine Hydrobromide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Galantamine Hydrobromide Market

• 29.1. Africa Galantamine Hydrobromide Market Overview
• 29.2. Africa Galantamine Hydrobromide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Galantamine Hydrobromide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Galantamine Hydrobromide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Galantamine Hydrobromide Market Competitive Landscape And Company Profiles

• 30.1. Galantamine Hydrobromide Market Competitive Landscape
• 30.2. Galantamine Hydrobromide Market Company Profiles
  • 30.2.1. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sandoz International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Ajinomoto Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Aurobindo Pharma Limited Overview, Products and Services, Strategy and Financial Analysis

31. Galantamine Hydrobromide Market Other Major And Innovative Companies

• 31.1. Dr. Reddy's Laboratories Ltd.
• 31.2. Jubilant Pharmova Limited
• 31.3. Cohance Lifesciences Limited
• 31.4. Indena S.p.A.
• 31.5. ScinoPharm Taiwan Ltd.
• 31.6. Estechpharma Co. Ltd.
• 31.7. Nortec Quimica S.A.
• 31.8. Metrochem API Private Limited
• 31.9. Sanochemia Pharmazeutika AG
• 31.10. Pellets Pharma Limited
• 31.11. Midas Pharma GmbH
• 31.12. Jubilant Generics
• 31.13. Capital Farma
• 31.14. Wuhan Shiji Pharmaceutical Co. Ltd.
• 31.15. Credo Life Sciences Pvt. Ltd.

32. Global Galantamine Hydrobromide Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Galantamine Hydrobromide Market

34. Recent Developments In The Galantamine Hydrobromide Market

35. Galantamine Hydrobromide Market High Potential Countries, Segments and Strategies

• 35.1 Galantamine Hydrobromide Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Galantamine Hydrobromide Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Galantamine Hydrobromide Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34856_Galantamine_Hydrobromide_GMR_2025